共 118 条
[1]
Bonadonna G(1976)Combination chemotherapy as an adjuvant treatment in operable breast cancer N Engl J Med 294 405-410
[2]
Brusamolino E(2010)Cyclophosphamide, methotrexate, and fluorouracil; oral cyclophosphamide; levamisole; or no adjuvant therapy for patients with high-risk, premenopausal breast cancer Cancer 116 2081-2089
[3]
Valagussa P(1992)Adjuvant chemotherapy of breast cancer. NIH consensus development conference, July 14–16, 1980 Cancer Treat Res 60 371-374
[4]
Rossi A(2005)Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials Lancet 365 1687-1717
[5]
Brugnatelli L(2012)Comparisons between different polychemotherapy regimens for early breast cancer: meta-analyses of long-term outcome among 100,000 women in 123 randomised trials Lancet 379 432-444
[6]
Brambilla C(2000)Molecular portraits of human breast tumours Nature 406 747-752
[7]
Ejlertsen B(2012)Responsiveness of intrinsic subtypes to adjuvant anthracycline substitution in the NCIC.CTG MA.5 randomized trial Clin Cancer Res 18 2402-2412
[8]
Mouridsen HT(2010)Prognostic and predictive value of the 21-gene recurrence score assay in postmenopausal women with node-positive, oestrogen-receptor-positive breast cancer on chemotherapy: a retrospective analysis of a randomised trial Lancet Oncol 11 55-65
[9]
Jensen MB(2015)Development and verification of the PAM50-based Prosigna breast cancer gene signature assay BMC Med Genet 8 54-345
[10]
Andersen J(2014)Austrian Breast and Colorectal Cancer Study Group. Predicting distant recurrence in receptor-positive breast cancer patients with limited clinicopathological risk: using the PAM50 risk of recurrence score in 1478 postmenopausal patients of the ABCSG-8 trial treated with adjuvant endocrine therapy alone Ann Oncol 25 339-953